Phase
Condition
Obesity
Diabetes Prevention
Hypertriglyceridemia
Treatment
Placebo
RGT001-075
Clinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age ≥ 18 and ≤ 75 years
Have a BMI ≥27 kg/m² and ≤ 45 kg/m²
Have had a stable body weight for the 3 months prior to randomization
Exclusion
Exclusion Criteria:
Have obesity induced by other endocrinologic disorders or diagnosed monogenetic orsyndromic forms of obesity
Have a prior or planned surgical treatment for obesity
Have or plan to have endoscopic and/or device-based therapy for obesity
Have any prior diagnosis of diabetes
Have an electrocardiogram (ECG) with abnormalities
Have a history of Major Depressive Disorder (MDD) or other severe psychiatricdisorders within the last 2 years
Have a history of suicide attempt.
Study Design
Connect with a study center
Velocity Clinical Research
Los Angeles, California 90057
United StatesSite Not Available
Velocity Clinical Research
Valparaiso, Indiana 46383
United StatesSite Not Available
Velocity Clinical Research
Omaha, Nebraska 68134
United StatesSite Not Available
Velocity Clinical Research
Vestal, New York 13850
United StatesSite Not Available
Velocity Clinical Research
Durham, North Carolina 27701
United StatesSite Not Available
Velocity Clinical Research
Cleveland, Ohio 44122
United StatesSite Not Available
Velocity Clinical Research
Medford, Oregon 97504
United StatesSite Not Available
Velocity Clinical Research
East Greenwich, Rhode Island 02818
United StatesSite Not Available
Velocity Clinical Research
Dallas, Texas 75230
United StatesSite Not Available
Velocity Clinical Research
West Jordan, Utah 84088
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.